These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16298583)

  • 41. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
    Hanouneh IA; Miller C; Aucejo F; Lopez R; Quinn MK; Zein NN
    Liver Transpl; 2008 Jan; 14(1):53-8. PubMed ID: 18161839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Living donor liver transplantation for patients with hepatitis C virus cirrhosis: Tokyo experience.
    Sugawara Y; Makuuchi M
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S122-4. PubMed ID: 16234059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of recurrent hepatitis C.
    Gane E
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S28-37. PubMed ID: 12362295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
    Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Grazi G; Bernardi M; Andreone P
    Gut; 2007 Feb; 56(2):237-42. PubMed ID: 16798778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.
    Mukherjee S; Gilroy RK; McCashland TM; Schafer DF
    Transplant Proc; 2003 Jun; 35(4):1478-9. PubMed ID: 12826198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.
    Foruny JR; Bárcena R; Moreno A; Blázquez J; Manzano R; Gil-Grande LA; Moreno A; Nuño J
    Transplantation; 2006 Jul; 82(2):289-90. PubMed ID: 16858295
    [No Abstract]   [Full Text] [Related]  

  • 47. Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.
    Saab S; Wang V
    J Clin Gastroenterol; 2003 Aug; 37(2):155-63. PubMed ID: 12869888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation.
    Terrault NA
    Liver Transpl; 2003 Nov; 9(11):S95-S100. PubMed ID: 14586903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.
    Kwo PY; Saxena R; Cummings OW; Tector AJ
    Liver Transpl; 2007 Dec; 13(12):1710-3. PubMed ID: 18044743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hepatitis C in liver transplant recipients.
    Gordon FD; Kwo P; Vargas HE
    Liver Transpl; 2009 Feb; 15(2):126-35. PubMed ID: 19177439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy.
    Neff GW; Montalbano M; O'Brien CB; Nishida S; Safdar K; Bejarano PA; Khaled AS; Ruiz P; Slapak-Green G; Lee M; Nery J; De Medina M; Tzakis A; Schiff ER
    Transplantation; 2004 Nov; 78(9):1303-7. PubMed ID: 15548967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retransplantation for hepatitis C-related cirrhosis under long-term pegylated interferon therapy.
    Suárez F; Otero A; Gonzalez B; Gómez-Gutiérrez M; Arnal F; Vazquez JL
    Transplant Proc; 2004 Apr; 36(3):775-7. PubMed ID: 15110659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?
    Roche B; Samuel D
    J Hepatol; 2010 May; 52(5):630-2. PubMed ID: 20334948
    [No Abstract]   [Full Text] [Related]  

  • 54. Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis?
    Merli M; Gentili F; Giusto M; Attili AF; Corradini SG; Mennini G; Rossi M; Corsi A; Bianco P
    Dig Liver Dis; 2009 May; 41(5):345-9. PubMed ID: 19162574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy.
    Lee SJ; Cho YK; Na SY; Choi EK; Boo SJ; Jeong SU; Song HJ; Kim HU; Kim BS; Song BC
    Clin Mol Hepatol; 2016 Sep; 22(3):390-395. PubMed ID: 27572075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Jaundice developing in a patient with hepatitis C4 months after liver transplantation.
    Fiel MI; Schiano T
    Hepatology; 2009 Feb; 49(2):695-6. PubMed ID: 19177566
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of hepatitis C virus infection in the allograft.
    Neuberger J
    Liver Transpl; 2003 Nov; 9(11):S101-8. PubMed ID: 14586904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis.
    Hayashi PH; Mehia C; Joachim Reimers H; Solomon HS; Bacon BR
    J Clin Gastroenterol; 2006 Sep; 40(8):740-4. PubMed ID: 16940889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Preliminary results and complications of HCV treatment after liver transplantation].
    Pawłowska J; Teisseyre M; Jankowska I; Kaliciński P; Dzierzanowska-Fangrat K; Kluge P; Teisseyre J; Socha J; Woynarowski M
    Przegl Epidemiol; 2006; 60(4):677-83. PubMed ID: 17682748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection.
    Neff GW; delaGarza J; Shire N; Nishida S; O'Brien CB; Safdar K; Madariaga J; Schiff E; Ruiz P
    Transplant Proc; 2004 Dec; 36(10):3065-7. PubMed ID: 15686695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.